How Medical Devices Get Approved: The FDA Process

Aug 3
4 min read

From insulin pumps that help manage diabetes to pacemakers that regulate heart rhythms, medical devices have played a major role in modern healthcare. Before patients can access these devices , they must go through a regulated review process that is designed to help ensure their safety and effectiveness. In the United States, the process is overseen by the Food and Drug Administration (FDA), which evaluates these devices based on their risk level and intended use. This system matters because it shows how innovation and patient safety work together in healthcare.

To understand this system, we must know what counts as a medical device. A medical device is a product used to diagnose, prevent, monitor, treat or help manage a health condition. This includes everything from simple tools like bandages to more advanced technologies such as x-ray machines. The FDA regulates devices differently depending on the level of risk- Significant Risk or Non-significant Risk- which is why every device does not follow the exact same approval pathway. So the bigger the risk there is to patients, the more evidence the FDA usually requires before the device can be sold.

The FDA groups medical devices into three classes based on risk. Class I devices are low risk and are usually subject to general controls, such as manufacturing standards and proper registration. Most are exempt from premarket review. Examples of Class I devices are scalpels, bandages, dental floss and stethoscopes. Class II devices are moderate risk and often need a 501(k) submission. The regulatory controls for Class II devices include labelling requirements, specific mandatory performance standards, and testing requirements. Examples of Class II devices include insulin pumps, diagnostic equipment, and contact lenses. Class III devices are high risk and usually require the most rigorous review because they support or sustain life, are implanted into the body or have potential for illness and/or injury. Examples of devices in this class are breast implants, cochlear implants, and vascular stents. This classification system helps the FDA match the device’s impact on patient health and which pathway of approval the device will go through.

There are three main FDA pathways medical devices will go through. The most common route for these moderate-risk medical devices is the 501(k) clearance process. In this pathway, the manufacturer shows that the new device is considerably equivalent to a device that is already on the market called a predicate. According to the FDA, a 501(k) submission must be made at least 90 days before the market unless the device is exempt. For higher-risk devices, manufacturers may need Premarket Approval or PMA, which is the FDA’s most rigorous device pathway and requires comprehensive and valid scientific evidence that the device is safe and effective for its intended use. A third pathway is the De Novo classification, which is used for low to moderate risk devices that do not have a predicate. If the FDA grants De Novo status, the device can become a new benchmark for future products. This pathway helps bring new technology to the market without the more demanding PMA process when the risk level does not justify it. A special exception is a humanitarian device exemption (HDE) application. These devices are for orphan devices and are to benefit patients in diagnosis or treatment of a condition that is affecting fewer than 4000 patients per year in the United States. This application is similar to the PMA. However, it does not need the effectiveness requirements meaning it needs to demonstrate safety and probable benefit.

Before approval, many devices must undergo preclinical testing and higher risk products require human studies or clinical trials. The FDA explains that devices are tested on people to help determine whether they are safe and effective. Researchers may need an Investigational Device Exemption or IDE to legally test a device in patients before full approval. These studies generate the evidence the FDA uses to decide whether a device should move forward in the approval process. After a manufacturer submits its application, the FDA review team examines the full data package and decides whether the device meets regulatory standards for each pathway. The agency may approve the device and clear it, ask for additional information or deny the application if the evidence is not strong enough. The time to review each product is dependent on the approval pathway and device complexity. This would imply that a PMA approval would generally take longer than a 501(k) clearance. In every case, the FDA’s goal is to make sure the device performs as intended without creating unnecessary risk for patients.

Many believe that after approval, the device is safe forever. That is however not the case as approval doesn’t end the process. After approval, the FDA will continue to monitor devices after they reach the market through systems that track performance and harmful events. If problems appear, the agency can investigate, require changes or issue recalls for the devices. This continuous oversight is important because some risks may only arise after a device is heavily used in real-world settings. This allows the FDA to protect public health long term.

The FDA approval process helps ensure medical devices are safe, effective and appropriate for patient use before entering the market. By sorting devices into classes and using different review pathways, a system that protects safety and innovation is set in place. Understanding this process gives a clear picture of how modern technology plays a role in advancing medicine and how it is regulated and trusted for patient care.